Codexis Q2 revenue $15.3M beats consensus; net loss narrows to $13.3M from $22.8M YoY

CODEXIS, INC.

2025-Q2 EPS reported -$0.40 revenue$22,871,000

Revenue $15.3M, beating $14.1M analyst consensus; net loss $13.3M ($0.16/sh) vs $22.8M ($0.32/sh) YoY.
Product gross margin improved to 72% from 45% YoY on shift to more profitable products.
Raised $27.3M via ATM and Innovatus loan; cash and investments balance $66.3M at Q2 end.
ECO Synthesis platform: over 30 opportunities, 6 presentations at TIDES USA, 3 CDMO collaborations.
Appointed Cynthia Collins (CEO of Nutcracker Therapeutics) to Board of Directors in April 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.